Jiangxi Puzoo Medical Device Co., Ltd was established in October 2021 and based in the Intelligent Manufacturing Industrial Park in Nanchang, Jiangxi, Puzoo Medical is a high-tech enterprise dedicated to the R&D, production, and sale of innovative medical devices. The company has been recognized as a National High-Tech Enterprise(2024), a Provincial-Level “Specialized, Refined, Unique, and New” Enterprise(2024), a National Sci-Tech SME(2022), and a Jiangxi Provincial Innovative Enterprise(2023). With R&D and production facilities spanning 2,000 square meters and a team of over 40 employees, Puzoo focuses on developing non-invasive medical solutions for functional brain disorders and chronic diseases. Our products are designed to support diagnosis, treatment, rehabilitation, and health improvement—particularly for the elderly, children, and women—across clinical disciplines such as psychiatry, neurology, rehabilitation, obstetrics & gynecology, and pediatrics. Guided by clinical needs, Puzoo integrates physical technologies including magnetic, electrical, acoustic, and optical stimulation to achieve application, combinatorial, and integrated innovation. We are committed to advancing our technologies and products toward modularization, digitalization, intelligence, connectivity, and domestic independence.

The company's R&D team, composed of a foreign fellow of the European Academy of Sciences, Yangtze River Scholar, National Science Fund for Distinguished Young Scholars recipient, professors, and doctors, is committed to achieving leadership through "technology, product, and service." The annual R&D investment accounts for over 20% of the company's operating revenue. A standardized R&D process system has been established, and the company has obtained both ISO 13485 and ISO 9001 Quality Management System certifications. As of the end of December 2024, the company had applied for 14 intellectual property rights (including one international invention patent), with 11 already granted. These include seven invention patents (four authorized), one utility model patent, four software copyrights, and three design patents, all of which have been fully granted.

The company has obtained market approval for nine products: Magnetic Field Stimulators (comprising four series with twenty models), Transcranial Magnetic and Cerebral Reflex Electrical Stimulators (three series with seven models), Electroencephalotherapy Instrument (A620), Transcranial Magnetic Stimulator (Multi-target), Transcranial Magnetic Stimulator (Navigation), Cognitive Dysfunction Assessment, Examination and Rehabilitation Training Software, Eye Movement Detection System, Physical Therapy Surface Electrodes, and Transcranial Electrical Stimulators. Additionally, it has four products under research and development, covering "magnetic, electrical, acoustic, and optical" technologies and spanning the entire health spectrum from "screening, diagnosis, treatment, rehabilitation, to health promotion."